- Home
- LPL vs PRCT Comparison
LPL vs PRCT Comparison
Compare LPL & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPL
- PRCT
- Stock Information
- Founded
- LPL 1985
- PRCT 2009
- Country
- LPL South Korea
- PRCT United States
- Employees
- LPL N/A
- PRCT N/A
- Industry
- LPL Industrial Machinery/Components
- PRCT Medical Specialities
- Sector
- LPL Technology
- PRCT Health Care
- Exchange
- LPL Nasdaq
- PRCT Nasdaq
- Market Cap
- LPL 3.4B
- PRCT 3.2B
- IPO Year
- LPL 2004
- PRCT 2021
- Fundamental
- Price
- LPL $3.92
- PRCT $51.35
- Analyst Decision
- LPL Sell
- PRCT Buy
- Analyst Count
- LPL 2
- PRCT 8
- Target Price
- LPL N/A
- PRCT $86.14
- AVG Volume (30 Days)
- LPL 299.6K
- PRCT 1.1M
- Earning Date
- LPL 08-05-2025
- PRCT 08-06-2025
- Dividend Yield
- LPL N/A
- PRCT N/A
- EPS Growth
- LPL N/A
- PRCT N/A
- EPS
- LPL N/A
- PRCT N/A
- Revenue
- LPL $19,437,582,152.00
- PRCT $249,121,000.00
- Revenue This Year
- LPL N/A
- PRCT $47.38
- Revenue Next Year
- LPL N/A
- PRCT $31.71
- P/E Ratio
- LPL N/A
- PRCT N/A
- Revenue Growth
- LPL 8.96
- PRCT 59.36
- 52 Week Low
- LPL $2.43
- PRCT $47.04
- 52 Week High
- LPL $4.31
- PRCT $103.81
- Technical
- Relative Strength Index (RSI)
- LPL 72.18
- PRCT 33.18
- Support Level
- LPL $3.71
- PRCT $51.00
- Resistance Level
- LPL $3.87
- PRCT $60.57
- Average True Range (ATR)
- LPL 0.09
- PRCT 3.28
- MACD
- LPL 0.04
- PRCT -0.64
- Stochastic Oscillator
- LPL 98.31
- PRCT 3.13
About LPL LG Display Co Ltd AMERICAN DEPOSITORY SHARES
LG Display Co Ltd is a South Korea-based company that is principally engaged in developing, manufacturing, and selling TFT-LCD and OLED display panels. The company's products consist of panels for notebook computers, monitors, televisions, smartphones, tablets, and others. The company conducts direct sales through overseas subsidiaries in several countries, including the United States, Germany, Japan, Taiwan, China, and Singapore. These subsidiaries conduct sales activities and offer technical support to clients. The company generates the majority of its revenue from overseas markets, with the rest from South Korea.
About PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.